Aisthesis Medical
Aisthesis Medical is revolutionizing acute and critical care with its AI-powered clinical decision support software, VIOSync. This platform aims to improve patient outcomes and optimize cost efficiency by providing high-impact solutions for intensive and critical care settings. VIOSync focuses on multi-pathology prediction using multi-modal data, personalized analytics via digital patient twins, a real-time clinical alerting mechanism, and a recommendation engine with underlying pathology explanations. The company is targeting life-threatening conditions where early detection leads to significant clinical and financial impact, such as sepsis, which is the number one cause of death in hospitals. VIOSync integrates with EHR/PDMS via IHE/HL7 standards, fuses multi-modal data to synthesize a digital patient twin, and delivers actionable insights for swift intervention.
Aisthesis Medical
Aisthesis Medical is revolutionizing acute and critical care with its AI-powered clinical decision support software, VIOSync. This platform aims to improve patient outcomes and optimize cost efficiency by providing high-impact solutions for intensive and critical care settings. VIOSync focuses on multi-pathology prediction using multi-modal data, personalized analytics via digital patient twins, a real-time clinical alerting mechanism, and a recommendation engine with underlying pathology explanations. The company is targeting life-threatening conditions where early detection leads to significant clinical and financial impact, such as sepsis, which is the number one cause of death in hospitals. VIOSync integrates with EHR/PDMS via IHE/HL7 standards, fuses multi-modal data to synthesize a digital patient twin, and delivers actionable insights for swift intervention.
TL;DR
Product: VIOSync — AI clinical decision support with Sepsis Prediction Index (SPI) and digital patient twins
Founded: 2022
Headcount: 9
Recent funding (site): $1.2M pre-seed announced by company
Tech: Explainable AI, multi-modal data fusion, EHR/PDMS integration (IHE/HL7)
Company Overview
Problem Domain
Acute and critical care deterioration detection (including sepsis prediction up to 48 hours earlier)
Founded
2022
Industry
MedTech / Clinical AI
Tech Stack
Funding Track Record
$1.2M
Company site announcement of $1.2M pre-seed with participation from TECS Capital
$240,000.00
Aggregate small grant funding listed in a company snapshot